Power, sample size and adaptation considerations in the design of group sequential clinical trials
组序贯临床试验设计中的功效、样本量与适应性AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要关注临床试验的组序贯设计、功效和样本量,未明确研究治疗效应识别或其他给定计量细分,因此暂不分类。
反馈分类问题组序贯临床试验设计中的功效、样本量与适应性AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
A class of flexible and asymptotically efficient group sequential designs is developed herein for one-sided and two-sided tests of the parameter of an exponential family. Efficiency is measured in terms of the expected sample size and power function, under prespecified constraints on the maximum sample size and Type I error probability. It is shown how these designs achieve asymptotic efficiency by adapting to the information about the unknown parameter during the course of the experiment. Moreover, they are very flexible and can circumvent the difficulties due to 'information time' versus 'calendar time' that arise in more complex settings such as time-sequential clinical trials comparing the failure times of two treatments.